seed
Stage
2
Investors
About
Axithra develops a photonics-based point-of-care device using Raman spectroscopy on a chip to rapidly detect and quantify the active free fraction of drugs in patient blood for therapeutic drug monitoring, currently under clinical investigation and not yet market authorized.
Explore Axithra's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.